BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3027331)

  • 1. Preparation, receptor binding, and fluorescence properties of hexestrol-fluorophore conjugates: evaluation of site of attachment, fluorophore structure, and fluorophore-ligand spacing.
    Fevig TL; Lloyd JE; Zablocki JA; Katzenellenbogen JA
    J Med Chem; 1987 Jan; 30(1):156-65. PubMed ID: 3027331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain.
    Landvatter SW; Katzenellenbogen JA
    J Med Chem; 1982 Nov; 25(11):1300-7. PubMed ID: 6292423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.
    Zablocki JA; Katzenellenbogen JA; Carlson KE; Norman MJ; Katzenellenbogen BS
    J Med Chem; 1987 May; 30(5):829-38. PubMed ID: 3033242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol.
    Ouellet R; Rousseau J; Brasseur N; van Lier JE; Diksic M; Westera G
    J Med Chem; 1984 Apr; 27(4):509-13. PubMed ID: 6323712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 1. Synthesis and estrogen receptor binding affinity of 2,2'- and 3,3'-disubstituted hexestrols.
    Hartmann RW; Schwarz W; Schönenberger H
    J Med Chem; 1983 Aug; 26(8):1137-44. PubMed ID: 6308256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor based imaging agents. 2. Synthesis and receptor binding affinity of side-chain halogenated hexestrol derivatives.
    Goswami R; Harsy SG; Heiman DF; Katzenellenbogen JA
    J Med Chem; 1980 Sep; 23(9):1002-8. PubMed ID: 6251218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
    Hartmann RW; Heindl A; Schönenberger H
    J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors.
    Köhle H; Krohn K; Leclercq G
    J Med Chem; 1989 Jul; 32(7):1538-47. PubMed ID: 2544725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations.
    Carlson KE; Coppey M; Magdelenat H; Katzenellenbogen JA
    J Steroid Biochem; 1989 Mar; 32(3):345-55. PubMed ID: 2539536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.
    Hartmann RW
    J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo.
    Landvatter SW; Kiesewetter DO; Kilbourn MR; Katzenellenbogen JA; Welch MJ
    Life Sci; 1983 Nov; 33(19):1933-8. PubMed ID: 6316052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically reactive estrogens: synthesis and estrogen receptor interactions of hexestrol ether derivatives and 4-substituted deoxyhexestrol derivatives bearing alkylating functions.
    Katzenellenbogen JA; McGorrin RJ; Tatee T; Kempton RJ; Carlson KE; Kinder DH
    J Med Chem; 1981 Apr; 24(4):435-50. PubMed ID: 6267281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of nonsteroidal estrogens: The effect of conformer populations on the binding affinity of meso- and dl-hexestrol to the estrogen receptor.
    Kilbourn MR; Arduengo AJ; Park JT; Katzenellenbogen JA
    Mol Pharmacol; 1981 May; 19(3):388-98. PubMed ID: 6267445
    [No Abstract]   [Full Text] [Related]  

  • 15. Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands.
    Anstead GM; Peterson CS; Pinney KG; Wilson SR; Katzenellenbogen JA
    J Med Chem; 1990 Oct; 33(10):2726-34. PubMed ID: 2213825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of 3,3'disubstituted hexestrol derivatives and their binding affinity to cytoplasmatic estrogen receptors (author's transl)].
    Hamacher H
    Arch Pharm (Weinheim); 1981 Jul; 314(7):631-44. PubMed ID: 6271092
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, receptor binding and target-tissue uptake of carbon-11-labeled carbamate derivatives of estradiol and hexestrol.
    Ali H; Rousseau J; Diksic M; van Lier JE
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):175-82. PubMed ID: 1318291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
    Hartmann RW; Heindl A; Schneider MR; Schönenberger H
    J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent.
    Shani J; Gazit A; Livshitz T; Biran S
    J Med Chem; 1985 Oct; 28(10):1504-11. PubMed ID: 2995668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.